AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32419303 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise combined with education and manual therapy
Number of subjects: 61
Study 32419303 — intervention group
Group type: COMPARATOR
Intervention: Exercise combined with education
Number of subjects: 61
Study 33973923 — intervention group
Group type: EXPERIMENTAL
Intervention: Bup/Nal treatment for 12 weeks
Number of subjects: 152
Study 33973923 — intervention group
Group type: COMPARATOR
Intervention: Detox treatment for up to 2 weeks
Number of subjects: 152
Study 33856337 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive targeted cryotherapy (crushed wetted ice in a plastic bag)
Number of subjects: 38
Study 33856337 — intervention group
Group type: COMPARATOR
Intervention: Chemical cold packs
Number of subjects: 38
Study 33341406 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg CaEDTA in Tris‐buffered saline nebulised with 250 mg tobramycin
Number of subjects: 25
Study 33341406 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Tris‐buffered saline) nebulised with 250 mg tobramycin
Number of subjects: 25
Study 32340910 — intervention group
Group type: EXPERIMENTAL
Intervention: Device (active mode)
Number of subjects: 59
Study 32340910 — intervention group
Group type: COMPARATOR
Intervention: Device (silent mode)
Number of subjects: 59
Study 36014910 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional canola oil (CO)
Number of subjects: 31
Study 36014910 — intervention group
Group type: EXPERIMENTAL
Intervention: High-oleic acid canola oil (HOCO)
Number of subjects: 31
Study 36014910 — intervention group
Group type: COMPARATOR
Intervention: Control oil blend (CON)
Number of subjects: 31
Study 32103280 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue avoidance training (CAT)
Number of subjects: 60
Study 32103280 — intervention group
Group type: COMPARATOR
Intervention: Control training
Number of subjects: 60
Study 32103280 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural effects
Number of subjects: 60
Study 34334394 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Activity Program (TAP) - outpatient version
Number of subjects: 54
Study 34334394 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study 34148150 — intervention group
Group type: EXPERIMENTAL
Intervention: Antisense oligonucleotides
Number of subjects: 0
Study 34148150 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35035537 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care with ‘step-up’ DMARD therapy
Number of subjects: 1
Study 35035537 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic therapy with NSAIDs and local corticosteroid injections
Number of subjects: 1
Study 34023412 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS anode stimulation of the M1
Number of subjects: 35
Study 34023412 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS anode stimulation of the SMA
Number of subjects: 35
Study 34023412 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 35
Study 32022863 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly somapacitan
Number of subjects: 301
Study 32022863 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily GH
Number of subjects: 301
Study 32022863 — intervention group
Group type: COMPARATOR
Intervention: Once-weekly placebo
Number of subjects: 301
Study 35915506 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release guanfacine (GXR)
Number of subjects: 160
Study 35915506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 34802425 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month telephone-based wellness/support intervention
Number of subjects: 450
Study 34802425 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month telephone-based exercise intervention
Number of subjects: 450
Study 34802425 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 450
Study 615709281 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis (54 mg) administered orally
Number of subjects: 15
Study 615709281 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis (6.9% THC cigarette)
Number of subjects: 15
Study 615709281 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaporized cannabis (Volcano)
Number of subjects: 15
Study 615709281 — intervention group
Group type: EXPERIMENTAL
Intervention: THC (3 and 10 mg/kg) administered to mice
Number of subjects: 15
Study 35168231 — intervention group
Group type: EXPERIMENTAL
Intervention: Tildrakizumab 100 mg
Number of subjects: 0
Study 33360173 — intervention group
Group type: COMPARATOR
Intervention: CD-LD IR
Number of subjects: 393
Study 33360173 — intervention group
Group type: EXPERIMENTAL
Intervention: CD-LD ER
Number of subjects: 393
Study 32302600 — intervention group
Group type: EXPERIMENTAL
Intervention: Music making activities
Number of subjects: 0
Study 32302600 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 34569871 — intervention group
Group type: EXPERIMENTAL
Intervention: Picture-based medication calendar
Number of subjects: 0
Study 34569871 — intervention group
Group type: COMPARATOR
Intervention: Routine care without calendar
Number of subjects: 0
Study 34180315 — intervention group
Group type: EXPERIMENTAL
Intervention: Donasert®
Number of subjects: 312
Study 34180315 — intervention group
Group type: COMPARATOR
Intervention: Mirena®
Number of subjects: 312
Study 32696820 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver Intensive Education Program (CIEP)
Number of subjects: 90
Study 32696820 — intervention group
Group type: COMPARATOR
Intervention: Routine guidance/education (control group)
Number of subjects: 90
Study 36374769 — intervention group
Group type: COMPARATOR
Intervention: MOD-EX (Moderate-Intensity Exercise)
Number of subjects: 145
Study 36374769 — intervention group
Group type: COMPARATOR
Intervention: VIG-EX (Vigorous-Intensity Exercise)
Number of subjects: 145
Study 36374769 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance and Resistance Exercise (Acute)
Number of subjects: 145
Study 32594702 — intervention group
Group type: EXPERIMENTAL
Intervention: B-flow + CDFI
Number of subjects: 67
Study 32594702 — intervention group
Group type: COMPARATOR
Intervention: CDFI alone
Number of subjects: 67
Study 33522904 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based Lifestyle-integrated Functional Exercise (gLiFE)
Number of subjects: 30
Study 33522904 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Lifestyle-integrated Functional Exercise (LiFE)
Number of subjects: 30
Study 36126514 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 0
Study 36126514 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 0
Study 34165835 — intervention group
Group type: EXPERIMENTAL
Intervention: Four implants in maxillary overdentures
Number of subjects: 26
Study 34165835 — intervention group
Group type: EXPERIMENTAL
Intervention: Denture supported by four implants
Number of subjects: 26
Study 34165835 — intervention group
Group type: COMPARATOR
Intervention: Two implants in mandibular overdentures
Number of subjects: 26
Study 34726230 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant hGH treatment (various doses)
Number of subjects: 35
Study 34726230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 33279465 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline training for registered dietitian nutritionists (RDNs)
Number of subjects: 102
Study 33279465 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care including nutrition intervention
Number of subjects: 102
Study 36216216 — intervention group
Group type: EXPERIMENTAL
Intervention: Zein
Number of subjects: 13
Study 36216216 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein
Number of subjects: 13
Study 36216216 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein isolate (Whey)
Number of subjects: 13
Study 36216216 — intervention group
Group type: EXPERIMENTAL
Intervention: α-lactalbumin (ALac)
Number of subjects: 13
Study 36216216 — intervention group
Group type: EXPERIMENTAL
Intervention: Maltodextrin carbohydrate (Carb)
Number of subjects: 13
Study 34464358 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose convalescent plasma (3 units) plus standard treatment
Number of subjects: 105
Study 34464358 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment alone)
Number of subjects: 105
Study 34464358 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher cumulative amount of neutralizing antibodies plus standard treatment
Number of subjects: 105
Study 32822962 — intervention group
Group type: EXPERIMENTAL
Intervention: Class 3 (strong families/attachment)
Number of subjects: 216
Study 32822962 — intervention group
Group type: EXPERIMENTAL
Intervention: Class 1 (child welfare/multi-problem families)
Number of subjects: 216
Study 32822962 — intervention group
Group type: EXPERIMENTAL
Intervention: Class 2 (mental-health/angry-oppositional)
Number of subjects: 216
Study 32822962 — intervention group
Group type: EXPERIMENTAL
Intervention: All classes
Number of subjects: 216
Study 32822962 — intervention group
Group type: COMPARATOR
Intervention: Classes 1, 2, and 3
Number of subjects: 216
Study 35836148 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program based on the health belief model (HBM), 8 sessions long
Number of subjects: 280
Study 35836148 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 280
Study 34314402 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar plate fixation (operative treatment)
Number of subjects: 90
Study 34314402 — intervention group
Group type: COMPARATOR
Intervention: Cast immobilization (nonoperative treatment)
Number of subjects: 90
Study 32171564 — intervention group
Group type: EXPERIMENTAL
Intervention: HyFlex CM (HCM)
Number of subjects: 80
Study 32171564 — intervention group
Group type: COMPARATOR
Intervention: WaveOne Gold (WOG)
Number of subjects: 80
Study 32171564 — intervention group
Group type: COMPARATOR
Intervention: OneCurve (OC)
Number of subjects: 80
Study 32171564 — intervention group
Group type: COMPARATOR
Intervention: HyFlex EDM (HEDM)
Number of subjects: 80
Study 35641364 — intervention group
Group type: EXPERIMENTAL
Intervention: Resorbable magnesium scaffold (RMS)
Number of subjects: 30
Study 35641364 — intervention group
Group type: COMPARATOR
Intervention: Biodegradable polymer sirolimus eluting stents (BP‐SES)
Number of subjects: 30
Study 35641364 — intervention group
Group type: COMPARATOR
Intervention: Durable polymer everolimus eluting stents (DP‐EES)
Number of subjects: 30
Study 35546018 — intervention group
Group type: EXPERIMENTAL
Intervention: ICS treatment
Number of subjects: 84
Study 35546018 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 84
Study 35546018 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast + Leucodif
Number of subjects: 84
Study 35546018 — intervention group
Group type: EXPERIMENTAL
Intervention: ICS + Leucodif
Number of subjects: 84
Study 33834608 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg L-Cystine and 250 mg L-Glutathione
Number of subjects: 124
Study 33834608 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 33834608 — intervention group
Group type: COMPARATOR
Intervention: 250 mg reduced L-Glutathione
Number of subjects: 124
Study 33834608 — intervention group
Group type: COMPARATOR
Intervention: 500 mg L-Cystine
Number of subjects: 124
Study 34156693 — intervention group
Group type: EXPERIMENTAL
Intervention: RefluG™ (galactomannan-based formulation), one sachet three times per day for 14 days
Number of subjects: 60
Study 34156693 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34156693 — intervention group
Group type: EXPERIMENTAL
Intervention: RefluG™
Number of subjects: 60
Study 34156693 — intervention group
Group type: COMPARATOR
Intervention: RefluG™ and Placebo
Number of subjects: 60
Study 32086918 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with Dermatophagoides Farinae
Number of subjects: 72
Study 32086918 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 72
Study 32086918 — intervention group
Group type: COMPARATOR
Intervention: Comparison between SLIT and Control group
Number of subjects: 72
Study 34085881 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplement
Number of subjects: 88
Study 34085881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 34085881 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Synbiotic and Placebo)
Number of subjects: 88
Study 33767795 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% Satureja khuzestanica vaginal cream
Number of subjects: 84
Study 33767795 — intervention group
Group type: COMPARATOR
Intervention: 1% clotrimazole vaginal cream
Number of subjects: 84
Study 36242607 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for insomnia (CBTI)
Number of subjects: 658
Study 36242607 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 658
Study 32529788 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 37679711 — intervention group
Group type: EXPERIMENTAL
Intervention: ACAT program and treatment‐as‐usual
Number of subjects: 49
Study 37679711 — intervention group
Group type: COMPARATOR
Intervention: treatment‐as‐usual
Number of subjects: 49
Study 36285551 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine plus carvedilol
Number of subjects: 300
Study 36285551 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol
Number of subjects: 300
Study 35435785 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital CBTi intervention (Sleepio)
Number of subjects: 75
Study 33789610 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid infusion (200 ml IV at 100 ml/h)
Number of subjects: 76
Study 33789610 — intervention group
Group type: COMPARATOR
Intervention: Placebo (200 ml IV)
Number of subjects: 76
Study 32867282 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingestion of omega‐3 long chain polyunsaturated fatty acids (n‐3 LCPUFA) and multivitamin supplements
Number of subjects: 136
Study 32867282 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 36239645 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy plus medical therapy
Number of subjects: 217
Study 36239645 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy only (control)
Number of subjects: 217
Study 33368782 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) treatment
Number of subjects: 121
Study 33368782 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 121
Study 32701239 — intervention group
Group type: EXPERIMENTAL
Intervention: Inverse ratio ventilation combined with positive end-expiratory pressure (PEEP)
Number of subjects: 63
Study 32701239 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 63
Study 36129479 — intervention group
Group type: EXPERIMENTAL
Intervention: Incontinence Health Belief Development Program (IHBDP) for 5 weeks
Number of subjects: 160
Study 32852222 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative labia
Number of subjects: 4513
Study 32852222 — intervention group
Group type: COMPARATOR
Intervention: Preoperative labia
Number of subjects: 4513
Study 35661491 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cTBS (20 sessions, 2 per day for 2 weeks)
Number of subjects: 59
Study 35661491 — intervention group
Group type: COMPARATOR
Intervention: Sham (placebo)
Number of subjects: 59
Study 32093625 — intervention group
Group type: COMPARATOR
Intervention: B + P (BONES plus Parent)
Number of subjects: 1434
Study 32093625 — intervention group
Group type: COMPARATOR
Intervention: B (BONES only)
Number of subjects: 1434
Study 32970955 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteochondroplasty with or without labral repair
Number of subjects: 214
Study 32970955 — intervention group
Group type: COMPARATOR
Intervention: Lavage with or without labral repair
Number of subjects: 214
Study 32970955 — intervention group
Group type: COMPARATOR
Intervention: Lavage
Number of subjects: 214
Study 32970955 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteochondroplasty
Number of subjects: 214
Study 33278911 — intervention group
Group type: EXPERIMENTAL
Intervention: BdLEA proteins identified and analyzed; 18 BdLEAs selected for qRT-PCR analysis.
Number of subjects: 67
Study 33278911 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcriptomic analysis of BdLEAs.
Number of subjects: 67
Study 33278911 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene Ontology (GO) annotation of BdLEAs.
Number of subjects: 67
Study 33278911 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of gene structure, evolutionary relationships, and protein motifs of BdLEAs.
Number of subjects: 67
Study 32051083 — intervention group
Group type: EXPERIMENTAL
Intervention: Concerta treatment
Number of subjects: 80
Study 32051083 — intervention group
Group type: EXPERIMENTAL
Intervention: Strattera treatment
Number of subjects: 80
Study 32051083 — intervention group
Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 80
Study 32051083 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 80
Study 32051083 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 80
Study 37660037 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivmecillinam 400 mg three times daily and amoxicillin/clavulanic acid 500/125 mg three times daily for 10 days
Number of subjects: 330
Study 37660037 — intervention group
Group type: COMPARATOR
Intervention: Oral ciprofloxacin 500 mg twice daily or oral trimethoprim–sulfamethoxazole 800 mg/160 mg twice daily or intravenous ertapenem 1 g once daily for 7–10 days
Number of subjects: 330
Study 32892493 — intervention group
Group type: EXPERIMENTAL
Intervention: IL vitamin D3 every 4 weeks
Number of subjects: 60
Study 32892493 — intervention group
Group type: EXPERIMENTAL
Intervention: IL tuberculin PPD every 2 weeks
Number of subjects: 60
Study 32892493 — intervention group
Group type: COMPARATOR
Intervention: IL saline every 2 weeks
Number of subjects: 60
Study 32031091 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 μg of dexmedetomidine in 0.3 ml of normal saline (Group D)
Number of subjects: 70
Study 32031091 — intervention group
Group type: COMPARATOR
Intervention: 0.3 ml of normal saline alone (Group S)
Number of subjects: 70
Study 35131893 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI) via the ELLIPTA DPI (n=1081)
Number of subjects: 2236
Study 35131893 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=1155)
Number of subjects: 2236
Study 34924360 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash transfer of $C1000
Number of subjects: 392
Study 34924360 — intervention group
Group type: COMPARATOR
Intervention: Physical distancing guidelines alone
Number of subjects: 392
Study 35550164 — intervention group
Group type: EXPERIMENTAL
Intervention: CRISP tool implementation
Number of subjects: 1
Study 32212997 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Ureteral Extravesical Reimplantation (LUER)
Number of subjects: 26
Study 32212997 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic-Assisted Extracorporeal Ureteral Tapering Repair (EUTR)
Number of subjects: 26
Study 35108409 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching sides one, three, and five times during mastication
Number of subjects: 29
Study 35108409 — intervention group
Group type: EXPERIMENTAL
Intervention: Freestyle mastication
Number of subjects: 29
Study 34190938 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation Effectiveness Tool ‐ Modified Brazilian Version
Number of subjects: 435
Study 32772395 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-implant (G-I)
Number of subjects: 37
Study 32772395 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-implant overdentures (G-II)
Number of subjects: 37
Study 32772395 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed 4-implant complete denture (G-III)
Number of subjects: 37
Study 35713772 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib adjuvant therapy
Number of subjects: 0
Study 35713772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34023577 — intervention group
Group type: EXPERIMENTAL
Intervention: Masimo device hemoglobin (SpHb)
Number of subjects: 380
Study 34023577 — intervention group
Group type: COMPARATOR
Intervention: Cyanomethemoglobin (HiCN)
Number of subjects: 380
Study 35396340 — intervention group
Group type: EXPERIMENTAL
Intervention: CIAT-Plus
Number of subjects: 201
Study 35396340 — intervention group
Group type: EXPERIMENTAL
Intervention: M-MAT
Number of subjects: 201
Study 35396340 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 201
Study 34656261 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 39
Study 34656261 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 39
Study 32605447 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg cannabidiol
Number of subjects: 0
Study 32605447 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg cannabidiol
Number of subjects: 0
Study 32605447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34524102 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced SMS text message-based intervention (1-8 messages/month)
Number of subjects: 40
Study 34524102 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced SMS text message-based intervention
Number of subjects: 40
Study 34524102 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 40
Study 33031956 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-driven entertainment education intervention
Number of subjects: 0
Study 33031956 — intervention group
Group type: COMPARATOR
Intervention: Attention-control intervention
Number of subjects: 0
Study 35241098 — intervention group
Group type: EXPERIMENTAL
Intervention: CoQ10 (120 mg)
Number of subjects: 101
Study 35241098 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 35060336 — intervention group
Group type: EXPERIMENTAL
Intervention: Just-in-time planning intervention (JITPI)
Number of subjects: 386